News
Article
Author(s):
In case you missed it, this week we had news about the AHEAD atopic dermatitis treatment recommendations, positive long-term results for roflumilast cream 0.05% in pediatric patients, line-field optical coherence tomography for dermal fillers, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Rates of infection did not correlate with disease severity, however.
Researchers tailored screening and surveillance schedules to individual risk of patients.
A recent study found after 6 months, CGF therapy resulted in a sustained increase in terminal hair density without significant adverse events.
At the conclusion of their roundtable event, Rocco Serrao, MD, FAAD; Latanya Benjamin, MD, FAAD; and Anthony Nuara, MD, PhD, discuss final considerations for tailoring vitiligo treatment plans.
Biologics work by inhibiting inflammatory cytokines, but a small percentage of patients may experience “paradoxical psoriasis.”
Approximately 8.8% of patients achieved complete response a year after onset of diphenylcyclopropenone therapy.
Bullous pemphigoid in youth is rare and can be missed due to negative BP180 ELISA results, complicating timely diagnosis in children.
The findings support the idea that Botox can enhance emotional well-being and self-confidence, although it did not notably impact the quality of life.
The study found that after 4 weeks of using the action plan, AD severity decreased markedly, with many patients achieving mild AD status.
The AHEAD recommendations focus on achieving disease control in atopic dermatitis by allowing patients to identify key symptoms and clinicians to select matching outcomes to guide therapy, aiming for a higher standard of care.
Researchers say further studies are needed to understand the effects of photoactivation, if any, in combination with PRP.
Results from the study highlight that the therapy improves AD symptoms over time, with 71.9% of participants achieving substantial improvement.
By setting higher treatment goals, the AHEAD recommendations emphasize the importance of achieving optimal targets for both skin clearance and itch relief in atopic dermatitis.
A recent review highlighted how AI can be used to enhance diagnostic accuracy, consultations, treatment planning, and patient education.
One hundred patients with AK rated their therapies with the TSQM and Likert scale, and shared their treatment needs regarding goals, cost, type, duration, and location.
Learn more about the in-depth topics covered in the August 2024 supplement of Dermatology Times.
Learn more about the in-depth topics covered in the August 2024 print issue of Dermatology Times.
At T0, skin layers appeared normal, and at T1, filler deposits were clearly visible as hyporeflective areas.
Researchers observed significant improvements in roughness and redness in patients treated with the non-cross-linked compound.
Chronic hand eczema patients with high corticosteroid phobia are less likely to follow prescribed treatments, indicating a need for improved education.
Researchers identified KLB and EIF3C as potential biomarkers for vitiligo and AA, offering new targets for early diagnosis and treatment.
Dermatology Times is recapping our top expert interviews from the month of August.
Dermatology Times is looking back on the top stories in dermatology from the month of August.
Recent studies found that PRP therapy leads to noticeable decreases in hair shedding and increases in hair thickness.
Throughout the month of August, Dermatology Times covered psoriasis news related to Alumis Inc’s phase 3 trial of ESK-001 for plaque psoriasis, AbbVie’s Science of Skin event, and more.